TABLE 3.
Strain | No. of C sources (PM1 and PM2; 190 compounds) | No. of N sources (PM3; 95 compounds) | No. of P sources (PM4; 59 compounds) | No. of S sources (PM4; 35 compounds) | Total no. of sources |
---|---|---|---|---|---|
KT2440(pCAR1)b | 22 (3, 19) | 18 (1, 17) | 22 (5, 17) | 4 (0, 4) | 66 (9, 57) |
KT2440 (pCAR1Δpmr)c | 13 (13, 0) | 4 (4, 0) | 5 (2, 3) | 1 (1, 0) | 23 (20, 3) |
KT2440 (pCAR1Δpnd)c | 10 (8, 2) | 4 (4, 0) | 8 (5, 3) | 0 | 22 (17, 5) |
KT2440 (pCAR1Δphu)c | 10 (9, 1) | 1 (0, 1) | 4 (0, 4) | 0 | 15 (9, 6) |
KT2440 (pCAR1ΔpmrΔpnd)c | 11 (9, 2) | 1 (0, 1) | 6 (0, 6) | 0 | 18 (9, 9) |
KT2440 (pCAR1ΔpmrΔphu)c | 10 (7, 3) | 2 (0, 2) | 7 (5, 2) | 1 (1, 0) | 20 (13, 7) |
Two independent analyses were performed with each strain for each compound, and cellular respiration activity was compared among the four combinations. The numbers in parentheses in columns 2 to 6 indicate the numbers of compounds with which cell respiration increased (left) or decreased (right).
The results from KT2440(pCAR1) were compared with those from KT2440 (9).
The results from NAP gene disruptants were compared with those from KT2440(pCAR1).